Physician profile
Steven Naide
NPI 1548204118
$2,387.91
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $160 · 2021: $958 · 2022: $427 · 2023: $134 · 2024: $16.70 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,069.62 | 2019-2025 | Gmk Sphere |
| Stryker Corporation | $582.73 | 2020-2025 | Mako |
| Zimmer Biomet Holdings, INC. | $156.87 | 2019-2021 | |
| Pacira Therapeutics, INC. | $123.30 | 2020-2021 | |
| Orthalign INC | $99.66 | 2022 | |
| Sanofi-Aventis U.S. LLC | $66.63 | 2019-2020 | |
| Si-Bone, INC. | $57.06 | 2019 | |
| Djo, LLC | $31.89 | 2025 | Cmf |
| Vertex Pharmaceuticals Incorporated | $29.31 | 2025 | |
| Kci USA, INC. | $28.97 | 2022-2023 | Prevena |
| Depuy Synthes Sales INC. | $24.28 | 2019 | |
| Heron Therapeutics, INC. | $21.66 | 2021 | |
| Abbott Laboratories | $19.19 | 2025 | Eterna |
| Ethicon US, LLC | $16.71 | 2019 | |
| Smith+Nephew, INC. | $16.70 | 2024 | Pico 14, Renasys Touch |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $16.65 | 2019 | |
| Pfizer INC. | $13.90 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Naide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.